Clinical trials of surfactant replacement in europe

Neonatology

Volumn 71, Issue 1, 1997, Pages 8-12

  Halliday, Henry L ^a,b  

^a ROYAL MATERNITY HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; LUNG SURFACTANT EXTRACT; TURFSURF; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; META ANALYSIS; NEWBORN; PATENT DUCTUS ARTERIOSUS; POSITIVE END EXPIRATORY PRESSURE; PRENATAL CARE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

CLINICAL TRIALS; EUROPE; HUMANS; INFANT, NEWBORN; LUNG; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0031007819     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000244445     Document Type: Article

References (31)

1. Morley CJ, Bangham AD, Miller N, Davis JA: Dry artificial surfactant and its effect on very premature babies, Lancet 1981;1:64-68.
2. Wilkinson AR, Jenkins PA, Jeffrey JA: Two controlled trials of dry artificial lung surfactant: early effects and later outcome in babies with surfactant: Early effects and later outcome in babies with surfactant deficiency, Lancet 1985;2:287-291.
3. Ten Centre Study Group: Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies, Br Med J 1987:294:991-996.
4. Halliday HL, McClure G, Reid MMcC, Lappin TR, Meban C, Thomas PS: Controlled trial of artificial surfactant to prevent respiratory distress syndrome, Lancet 1984:1: 476-478.
5. Gortner L, Bernsau U, Hellwege HH, Hieronimi G, Jorch G, Reiter HL: A multiccntrc randomized controlled trial of bovine surfactant for prevention of respiratory distress syndrome, Lung 1990; 165(suppl): 864-869.
6. Noack G, Bcrggrcn P, Curstedt T, Grossmann G, Herin P, Mortensson W, Nilsson R, Robertson B: Severe neonatal respiratory distress syndrome treated with the isolated phospholipid fraction of natural surfactant, Acta Pacdiatr Scand 1987: 76:697-705.
7. Collaborative European Mullicenter Study Group: Surfactant icplace-ment therapy for severe neonatal respiratory distress syndrome: An international randomized clinical trial, Pediatrics 1988:82:683-691.
8. Horbar JD, Soli RF, Schachingcr H, Kewitz G, Versmold HT, Lindner W, Due G, Mieth D, Linderkamp O, Zilow EP, Lcmburg P, von Loewc-nich V, Brand M, Minoli I, Moro G, Riegcl KP, Roos R, Weiss L, Luccy JF: A European multiccnter randomized trial of single dose surfactant therapy for idiopathic respiratory distress syndrome, Eur J Pediatr 1990:149:416-423.
9. OSIRIS Collaborative Group: Early versus delayed neonatal administration of a synthetic surfactant - the judgement of Osiris, Lancet 1992: 340:1363-1369.
10. Hallman M, Merritt TA, Jarvenpaa AL, Boynton B, Mannino F, Gluck L, Moore T, Edwards D: Excgenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trial, J Pediatr 1985; 106: 963-969.
11. Halliday HL, Tarnow-Mordi WO, Corcoran JD, Patterson CC European Multiccntrc Study Group: Multiccntrc randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial), Arch Dis Child 1993:69:276-280.
12. Verder H, Robertson B, Grciscn B, Ebbcsen F, Albertson P, Lundstrom K, Jacobsen T, for the Danish-Swed-ish Multiccnter Study Group: Surfactant therapy and nasal continuous positive airway pressure for newborn with respiratory distress syndrome, N Engl J Med 1994:331: 1051-1055.
13. Scgerer H, van Gcldcr W, Angenent FWM, van Wocrkcns LJPM, Curstedt T, Obladcn M, Lachmann B: Pulmonary distribution and efficacy of exogenous surfactant in lung-la-vaged rabbits are influenced by the instillation technique, Pediatr Res 1993:34:490-494.
14. Saugstad OD, Halliday HL, Robertson B, Spccr CP: Replacement therapy with porcine natural surfactant -current status and future challenges, Biol Neonate 1993:64:269-278.
15. Cosmi EV: Prenatal administration of surfactant, Prenatal Neonatal Med 1996;1:109-111.
16. Shinwell ES, Robertson B, Saugstad OD, Halliday HL, Speer CP: Update on surfactant therapy, Biol Neonate 1995;67:2-12.
17. Avery ME: Unnecessary invasion of fetal privacy (editorial), Appi Car-diopulm Pathophysiol 1996:6:1.
18. Cosmi EV, La Torre T, Di Iorio R: Intraamniotic instillation of surfactant for prevention of neonatal respiratory distress syndrome (RDS): A preliminary report, Appi Cardio-pulrn Pathophysiol 1996;6:3-5.
19. Egberts J, dc Winter JP, Sedin G, de Kleine M, Brobergcr U, van Bel F, Curstedt T, Robertson B: Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks’ gestation: A randomized trial, Pediatrics 1993:92:768- 774.
20. Halliday HL: Natural vs synthetic surfactants in neonatal respiratory distress syndrome, Drugs 1996:51: 226-237
21. Speer CP, Gefeller O, Groneck P, Laufkötter E, Roll C, Hannsler L, Harms K, Herting E, Bocnish H, Windeier J, Robertson B: Randomized clinical trial of surfactant therapy for neonatal respiratory distress syndrome: Comparison of two treatment regimens with natural surfactant preparations, Arch Dis Child 1995;72:F8-F13.
22. Halliday HL, Speer CP, Robertson B Treatment of severe meconium aspiration syndrome with porcine surfactant, Eur J Pcdiatr 1996:155:1047-1051.
23. Findlay RD, Tacusch HW, Walther FJ: Surfactant replacement therapy for meconium aspiration syndrome, Pediatrics 1996:97:48-52.
24. Fetter WPF, Baerts W, Bos AP, van Lingcn RA: Surfactant replacement therapy in neonates with respiratory failure due to bacterial sepsis, Acta Paediatr 1995:84:14-16.
25. Choukroun ML, Lianas B, Apere H, Fayon M, Galperine RI, Guenard H, Démarquez JC: Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: A comparison between two surfactant preparations, Pediatr Pulmonol 1994; 18:272- 278.
26. Dimitriou G, Grccnough A, Giffin FJ, Karani J: The appearance of ‘early’ chest radiographs and the response to surfactant replacement therapy, Br J Radiol 1995:68:1177- 1180.
27. Alexander J, Milner AD: Lung volume and pulmonary blood flow measurements following exogenous surfactant, Eur J Pcdiatr 1995; 154: 392-397.
28. Schipper JA, van Sonderen L, Koppe JG, de Jongh FHC, GrifTioen RW, Dccn L: The influence of surfactant on functional residual capacity measured by nitrogen washout method in preterm newborns, Appl Cardiopulm Pathophysiol 1996:6: 19-24.
29. Corcoran JD, Sheehan O, O’Hare MMT, Halliday HL: Tracheal surfactant protein A following treatment with Curosurf, Appl Cardiopulm Pathophysiol 1995:5:245- 248.
30. Gormally SM, Clarke TA, Krishnan A, Ali M, Matthews TG: Surfactant therapy in respiratory' distress syndrome: The effect of a learning curve in improving outcome, Irish J MedSci 1993:162:458-461.
31. Robertson B: New targets for surfactant replacement therapy: Experimental and clinical aspects, Arch Dis Child 1996:75:F1-F3